Clinical trial

HeartPhone Cancer Survivors Trial 2019

NCT03953326

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2019-04-23

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2019-04-23Date precision: day

Registry last updated2026-02-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Leukemiaunresolved

Lymphomaunresolved

Interventions

HeartPhone appBEHAVIORAL

AcetylcholineDRUG · verified · RxNorm: acetylcholine

Sodium NitroprussideDRUG · verified · RxNorm: sodium nitroprusside

L-Arginine, N2-((4-Methylphenyl)Sulfonyl)-, Methyl EsterDRUG

Sponsors & collaborators

Penn State Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03953326 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.